Director/PDMR Shareholding

Source: RNS
RNS Number : 3982X
Dauch Corporation
20 March 2026
 

Dauch Corporation (the "Company") - Transaction Notification
2026 Award of PSUs and RSUs, Vesting of 2023 RSU and PSU Awards and Purchase of Shares

PDMR Dealings

20 March 2026

NOTIFICATION OF TRANSACTIONS BY PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMRs") IN SHARES OF COMMON STOCK OF PAR VALUE $0.01 EACH IN THE COMPANY ("Shares")

Dauch Corporation (NYSE, LSE: DCH), a global leader in the global automotive industry, announces the following transactions by PDMRs of Dauch Corporation (the "Company") relating to the grant and vesting of Performance Stock Units ("PSUs") and Restricted Stock Units ("RSUs") the Company's Amended and Restated 2018 Omnibus Incentive Plan and 2026 Inducement Omnibus Incentive Plan and Vesting of Performance Stock Units, along with the purchase of Shares by a PDMR.

2026 PSU Grant

PSUs were granted to the individuals named in the tables below, who are PDMRS of the Company, effective 2 February 2026,under the Company's 2018 Omnibus Incentive Plan, except for Markus Bannert, President - Metal Forming, who was granted PSUs effective 5 February 2026 under the Company's 2026 Inducement Omnibus Incentive Plan, following the Company's business combination with Dowlais Group plc, (the "Business Combination"). These PSUs, all of which are subject to the same general terms, entitle  the holders to receive Shares upon vesting following certification of achievement of pre-established performance objectives. Achievement of performance is based on the highest average share price of Company Common Stock achieved over a 20-day trading period during the measurement period ending March 31, 2029 ("Performance Period"). The holders must generally remain employed with the Company through the end of the Performance Period for 50% of the award to vest and through the one-year anniversary of that date for the other 50% of the award to vest, except for any earned amounts through the termination date in cases of a termination due to death and disability or a pro-rata portion of any such earned amounts upon a termination without cause.

2026 RSU Award

RSUs were granted to the individuals named in the tables below, who are PDMRs of the Company, effective 26 February 2026, under the Company's 2018 Omnibus Incentive Plan. Markus Bannert's RSUs were granted under the Company's 2026 Inducement Omnibus Incentive Plan. Subject to continued employment with the Company, RSUs granted under the 2026 RSU Award will vest on the third anniversary of the date of grant.

Vesting of 2023 RSU Award

The Company also announces the vesting of 2023 RSU Awards on 28 February 2026, as a result of which the individuals named in the tables below (who are PDMRs of the Company) became entitled to Shares. These awards were granted in 2023 and comprised of 40% of the Company's 2023 long-term incentive awards. These awards settled in Company Common Stock upon the third anniversary of the date of grant, subject to continued service with the Company.

Following this vesting, the Company withheld shares to satisfy tax obligations for the individuals named in the tables below.

Vesting of 2023 PSU Award

The Company also announces the vesting of 2023 PSU Awards on 28 February 2026 as a result of which the individuals named in the tables below (who are PDMRs of the Company) became entitled to Shares. These shares were issued as performance-based awards in 2023, comprising 60% of the Company's 2023 long-term incentive awards, including annual free cash flow targets for calendar years 2023, 2024 and 2025, each weighted at 20% of target. The remaining 40% of target was based on three-year cumulative free cash flow performance.

Following this vesting, the Company withheld shares to satisfy tax obligations for the individuals named in the tables below.

Purchase of Shares

The Company further announces that David Walker, a director and PDMR of the Company, purchased 35,000 Shares at a price of $5.20 on the New York Stock Exchange on 13 March 2026.

The attached notifications, which have been made in accordance with the requirements of the UK Market Abuse Regulation, provide further details.

 

1.

Details of person discharging managerial responsibility ("PDMR") / person closely associated with the ("PCA")

a)

Name

Markus Bannert

2.

Reason for the notification

a)

Position / status

President Metal Forming

b)

Initial notification / amendment


3.

Details of the issuer

a)

Name

Dauch Corporation

b)

LEI

254900SMQY98VFKNCC32

4.

Details of the transaction(s):  section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction I


a)

Date of the transaction

3 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

GBP - British Pound

f)

Nature of the transaction

Shares received in exchange for Dowlais Group shares under the combination transaction with Dauch that was completed February 3, 2026. The price stated below reflects the price per Dauch share in the combination, calculated with reference to the Dowlais share price at the close of trading on the last day before the combination became effective, adjusted for the exchange ratio and the cash consideration under the combination, rounded to the nearest whole UK pence.

g)

Summary


Price

Volume

Total


5.89

53954.00

317789.06

Aggregated

5.89

53954.00

317789.06

Transaction II


a)

Date of the transaction

5 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Grant of performance-based restricted stock units (PSUs) at target level performance. The actual number of PSUs that will be achieved is based on the highest average price of the Company's common stock achieved over any 20-day trading period during the measurement period ending March 31, 2029 ("Performance Period"). The number of PSUs earned by the reporting person will not exceed 300% of target. The PSUs will generally vest 50% at the end of the Performance Period and 50% on the one-year anniversary thereof.

g)

Summary


Price

Volume

Total


0.00

90909.00

0.00

Aggregated

0.00

90909.00

0.00

Transaction III


a)

Date of the transaction

5 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Shares representing a grant of restricted stock units (RSUs) that were assumed in connection with the business combination between Dauch and Dowlais Group plc and that will settle in common stock upon vesting, 27,521 on March 26, 2027 and 64,533 on March 11, 2028.

g)

Summary


Price

Volume

Total


0.00

92054.00

0.00

Aggregated

0.00

92054.00

0.00

Transaction IV


a)

Date of the transaction

26 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Grant of restricted stock units ("RSU") that will settle in common stock upon vesting on the third anniversary of the grant date. Each RSU represents a contingent right to receive one Share.

g)

Summary


Price

Volume

Total


0.00

83267.00

0.00

Aggregated

0.00

83267.00

0.00








 

1.

Details of person discharging managerial responsibility ("PDMR") / person closely associated with the ("PCA")

a)

Name

David C Dauch

2.

Reason for the notification

a)

Position / status

Chairman & CEO

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Name

Dauch Corporation

b)

LEI

254900SMQY98VFKNCC32

4.

Details of the transaction(s):  section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction I


a)

Date of the transaction

26 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Grant of restricted stock units ("RSU") that will settle in common stock upon vesting on the third anniversary of the grant date. Each RSU represents a contingent right to receive one Share.

g)

Summary


Price

Volume

Total


0.00

537667.00

0.00

Aggregated

0.00

537667.00

0.00

Transaction II


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

New York Stock Exchange

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Disposal of ordinary shares.

g)

Summary


Price

Volume

Total

1.

6.60

74646.00

492663.60

2.

6.60

146364.00

966002.40

Aggregated

6.60

221010.00

1488666.00

Transaction III


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Vest of restricted stock unites ("RSU"). Each RSU vests into one Share.

g)

Summary


Price

Volume

Total


0.00

166620.00

0.00

Aggregated

0.00

166620.00

0.00








 

1.

Details of person discharging managerial responsibility ("PDMR") / person closely associated with the ("PCA")

a)

Name

Terri Kemp

2.

Reason for the notification

a)

Position / status

SVP Chief of Staff

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Name

Dauch Corporation

b)

LEI

254900SMQY98VFKNCC32

4.

Details of the transaction(s):  section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction I


a)

Date of the transaction

26 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Grant of restricted stock units ("RSU") that will settle in common stock upon vesting on the third anniversary of the grant date. Each RSU represents a contingent right to receive one Share.

g)

Summary


Price

Volume

Total

 

0.00

79764.00

0.00

Aggregated

0.00

79764.00

0.00

Transaction II


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

New York Stock Exchange

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Disposal of ordinary shares.

g)

Summary


Price

Volume

Total

1.

6.60

12269.00

80975.40

2.

6.60

24723.00

163171.80

Aggregated

6.60

36992.00

244147.20

Transaction III


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Vest of restricted stock unites ("RSU"). Each RSU vests into one Share.

g)

Summary


Price

Volume

Total

 

0.00

27384.00

0.00

Aggregated

0.00

27384.00

0.00








 

1.

Details of person discharging managerial responsibility ("PDMR") / person closely associated with the ("PCA")

a)

Name

Michael Lynch

2.

Reason for the notification

a)

Position / status

President DL

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Name

Dauch Corporation

b)

LEI

254900SMQY98VFKNCC32

4.

Details of the transaction(s):  section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction I


a)

Date of the transaction

26 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Grant of restricted stock units ("RSU") that will settle in common stock upon vesting on the third anniversary of the grant date. Each RSU represents a contingent right to receive one Share.

g)

Summary


Price

Volume

Total

 

0.00

128509.00

0.00

Aggregated

0.00

128509.00

0.00

Transaction II


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

New York Stock Exchange

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Disposal of ordinary shares.

g)

Summary


Price

Volume

Total

1.

6.60

17526.00

115671.60

2.

6.60

34867.00

230122.20

Aggregated

6.60

52393.00

345793.80

Transaction III


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Vest of restricted stock unites ("RSU"). Each RSU vests into one Share.

g)

Summary


Price

Volume

Total

 

0.00

39120.00

0.00

Aggregated

0.00

39120.00

0.00

Transaction IV

 

a)

Date of the transaction

2 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Grant of performance-based restricted stock units (PSUs) at target level performance. The actual number of PSUs that will be achieved is based on the highest average price of the Company's common stock achieved over any 20-day trading period during the measurement period ending March 31, 2029 ("Performance Period"). The number of PSUs earned by the reporting person will not exceed 300% of target. The PSUs will generally vest 50% at the end of the Performance Period and 50% on the one-year anniversary thereof.

g)

Summary


Price

Volume

Total


0.00

287879.00

0.00

Aggregated

0.00

287879.00

0.00









 

1.

Details of person discharging managerial responsibility ("PDMR") / person closely associated with the ("PCA")

a)

Name

Fiona MacAulay

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Name

Dauch Corporation

b)

LEI

254900SMQY98VFKNCC32

4.

Details of the transaction(s):  section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction I


a)

Date of the transaction

5 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

GBP - British Pound

f)

Nature of the transaction

Shares received in exchange for Dowlais Group shares under the combination transaction with Dauch that was completed February 3, 2026. The price stated below reflects the price per Dauch share in the combination, calculated with reference to the Dowlais share price at the close of trading on the last day before the combination became effective, adjusted for the exchange ratio and the cash consideration under the combination, rounded to the nearest whole UK pence.

g)

Summary


Price

Volume

Total

 

5.89

1073.00

6319.97

Aggregated

5.89

1073.00

6319.97








 

1.

Details of person discharging managerial responsibility ("PDMR") / person closely associated with the ("PCA")

a)

Name

Christopher May

2.

Reason for the notification

a)

Position / status

EVP & CFO

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Name

Dauch Corporation

b)

LEI

254900SMQY98VFKNCC32

4.

Details of the transaction(s):  section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction I


a)

Date of the transaction

26 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Grant of restricted stock units ("RSU") that will settle in common stock upon vesting on the third anniversary of the grant date. Each RSU represents a contingent right to receive one Share.

g)

Summary


Price

Volume

Total

 

0.00

113738.00

0.00

Aggregated

0.00

113738.00

0.00

Transaction II


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

New York Stock Exchange

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Disposal of ordinary shares.

g)

Summary


Price

Volume

Total

1.

6.60

17526.00

115671.60

2.

6.60

34907.00

230386.20

Aggregated

6.60

52433.00

346057.80

Transaction III


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Vest of restricted stock unites ("RSU"). Each RSU vests into one Share.

g)

Summary


Price

Volume

Total

 

0.00

39120.00

0.00

Aggregated

0.00

39120.00

0.00

Transaction IV

 

a)

Date of the transaction

2 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Grant of performance-based restricted stock units (PSUs) at target level performance. The actual number of PSUs that will be achieved is based on the highest average price of the Company's common stock achieved over any 20-day trading period during the measurement period ending March 31, 2029 ("Performance Period"). The number of PSUs earned by the reporting person will not exceed 300% of target. The PSUs will generally vest 50% at the end of the Performance Period and 50% on the one-year anniversary thereof.

g)

Summary


Price

Volume

Total


0.00

287879.00

0.00

Aggregated

0.00

287879.00

0.00














 

1.

Details of person discharging managerial responsibility ("PDMR") / person closely associated with the ("PCA")

a)

Name

Tolga Oal

2.

Reason for the notification

a)

Position / status

President Driveline

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Name

Dauch Corporation

b)

LEI

254900SMQY98VFKNCC32

4.

Details of the transaction(s):  section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction I


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

New York Stock Exchange

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Disposal of ordinary shares.

g)

Summary


Price

Volume

Total

1.

6.60

14021.00

92538.60

2.

6.60

28164.00

185882.40

Aggregated

6.60

42185.00

278421.00

Transaction II


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Grant of restricted stock units ("RSU") that will settle in common stock upon vesting on the third anniversary of the grant date. Each RSU represents a contingent right to receive one Share.

g)

Summary


Price

Volume

Total

 

0.00

79764.00

0.00

Aggregated

0.00

79764.00

0.00

Transaction III


a)

Date of the transaction

28 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Vest of restricted stock unites ("RSU"). Each RSU vests into one Share.

g)

Summary


Price

Volume

Total

 

0.00

31296.00

0.00

Aggregated

0.00

31296.00

0.00








 

1.

Details of person discharging managerial responsibility ("PDMR") / person closely associated with the ("PCA")

a)

Name

Simon Mackenzie Smith

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Name

Dauch Corporation

b)

LEI

254900SMQY98VFKNCC32

4.

Details of the transaction(s):  section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction I


a)

Date of the transaction

5 February, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

Outside a trading venue

e)

Currency

GBP - British Pound

f)

Nature of the transaction

Shares received in exchange for Dowlais Group shares under the combination transaction with Dauch that was completed February 3, 2026. The price stated below reflects the price per Dauch share in the combination, calculated with reference to the Dowlais share price at the close of trading on the last day before the combination became effective, adjusted for the exchange ratio and the cash consideration under the combination, rounded to the nearest whole UK pence.

g)

Summary


Price

Volume

Total

 

5.89

14394.00

84780.66

Aggregated

5.89

14394.00

84780.66








 

1.

Details of person discharging managerial responsibility ("PDMR") / person closely associated with the ("PCA")

a)

Name

David Walker

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Name

Dauch Corporation

b)

LEI

254900SMQY98VFKNCC32

4.

Details of the transaction(s):  section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Transaction I


a)

Date of the transaction

13 March, 2026

b)

Description and identifier of the financial instrument

Share

c)

Identification Code

US0240611030

d)

Place of the transaction

New York Stock Exchange

e)

Currency

USD - United States Dollar

f)

Nature of the transaction

Purchase of shares.

g)

Summary


Price

Volume

Total

 

5.20

35000.00

182000.00

Aggregated

5.20

35000.00

182000.00








 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFAESUEMSELD